248 related articles for article (PubMed ID: 15304657)
1. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate.
Ntziachristos V; Schellenberger EA; Ripoll J; Yessayan D; Graves E; Bogdanov A; Josephson L; Weissleder R
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12294-9. PubMed ID: 15304657
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of chemotherapeutic effects in tumors using in vivo staining and correlative histology.
Choi HK; Yessayan D; Choi HJ; Schellenberger E; Bogdanov A; Josephson L; Weissleder R; Ntziachristos V
Cell Oncol; 2005; 27(3):183-90. PubMed ID: 16037639
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared fluorescent imaging of tumor apoptosis.
Petrovsky A; Schellenberger E; Josephson L; Weissleder R; Bogdanov A
Cancer Res; 2003 Apr; 63(8):1936-42. PubMed ID: 12702586
[TBL] [Abstract][Full Text] [Related]
4. Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography.
Graves EE; Yessayan D; Turner G; Weissleder R; Ntziachristos V
J Biomed Opt; 2005; 10(4):44019. PubMed ID: 16178652
[TBL] [Abstract][Full Text] [Related]
5. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
[TBL] [Abstract][Full Text] [Related]
6. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.
Schellenberger EA; Bogdanov A; Petrovsky A; Ntziachristos V; Weissleder R; Josephson L
Neoplasia; 2003; 5(3):187-92. PubMed ID: 12869301
[TBL] [Abstract][Full Text] [Related]
7. Tomographic fluorescence imaging of tumor vascular volume in mice.
Montet X; Figueiredo JL; Alencar H; Ntziachristos V; Mahmood U; Weissleder R
Radiology; 2007 Mar; 242(3):751-8. PubMed ID: 17325064
[TBL] [Abstract][Full Text] [Related]
8. Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.
Shi J; Udayakumar TS; Wang Z; Dogan N; Pollack A; Yang Y
Med Phys; 2017 Sep; 44(9):4795-4803. PubMed ID: 28626876
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography.
von Wallbrunn A; Höltke C; Zühlsdorf M; Heindel W; Schäfers M; Bremer C
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):745-754. PubMed ID: 17131149
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
11. In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against alpha4beta1 integrin.
Peng L; Liu R; Andrei M; Xiao W; Lam KS
Mol Cancer Ther; 2008 Feb; 7(2):432-7. PubMed ID: 18245670
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence tomographic imaging using a handheld-probe-based optical imager: extensive phantom studies.
Ge J; Erickson SJ; Godavarty A
Appl Opt; 2009 Nov; 48(33):6408-16. PubMed ID: 19935959
[TBL] [Abstract][Full Text] [Related]
13. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.
Gremse F; Theek B; Kunjachan S; Lederle W; Pardo A; Barth S; Lammers T; Naumann U; Kiessling F
Theranostics; 2014; 4(10):960-71. PubMed ID: 25157277
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT).
Razansky D; Baeten J; Ntziachristos V
Med Phys; 2009 Mar; 36(3):939-45. PubMed ID: 19378754
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence molecular tomography of an animal model using structured light rotating view acquisition.
Ducros N; Bassi A; Valentini G; Canti G; Arridge S; D'Andrea C
J Biomed Opt; 2013 Feb; 18(2):20503. PubMed ID: 23344841
[TBL] [Abstract][Full Text] [Related]
17. Multimodal fluorescence-mediated tomography and SPECT/CT for small-animal imaging.
Solomon M; Nothdruft RE; Akers W; Edwards WB; Liang K; Xu B; Suddlow GP; Deghani H; Tai YC; Eggebrecht AT; Achilefu S; Culver JP
J Nucl Med; 2013 Apr; 54(4):639-46. PubMed ID: 23447655
[TBL] [Abstract][Full Text] [Related]
18. Joint L1 and total variation regularization for fluorescence molecular tomography.
Dutta J; Ahn S; Li C; Cherry SR; Leahy RM
Phys Med Biol; 2012 Mar; 57(6):1459-76. PubMed ID: 22390906
[TBL] [Abstract][Full Text] [Related]
19. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging.
Haller J; Hyde D; Deliolanis N; de Kleine R; Niedre M; Ntziachristos V
J Appl Physiol (1985); 2008 Mar; 104(3):795-802. PubMed ID: 18202169
[TBL] [Abstract][Full Text] [Related]
20. Tomographic fluorescence mapping of tumor targets.
Montet X; Ntziachristos V; Grimm J; Weissleder R
Cancer Res; 2005 Jul; 65(14):6330-6. PubMed ID: 16024635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
